Stabilization and activation of p53 by the coactivator protein TAFII31

被引:36
作者
Buschmann, T
Lin, YH
Aithmitti, N
Fuchs, SY
Lu, H
Resnick-Silverman, L
Manfredi, JJ
Ronai, Z
Wu, XW [1 ]
机构
[1] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
[3] Oregon Hlth Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA
[4] Mt Sinai Sch Med, Derald H Ruttenberg Canc Ctr, New York, NY 10029 USA
关键词
D O I
10.1074/jbc.M007955200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Regulation of the stability of p53 is key to its tumor-suppressing activities. mdm2 directly binds to the amino-terminal region of p53 and targets it for degradation through the ubiquitin-proteasome pathway. The coactivator protein TAF(II)31 binds to p53 at the amino-terminal region that is also required for interaction with mdma. In this report, we demonstrate that expression of TAF(II)31 inhibits mdm2-mediated ubiquitination of p53 and increases p53 levels. TAF(II)31-mediated p53 stabilization results in activation of p53-mediated transcriptional activity and leads to p53-dependent growth arrest in fibroblasts. UV-induced stabilization of p53 coincides with an increase in p53-associated TAF(II)31 and a corresponding decrease in mdm2-p53 interaction. Non-p53 binding mutant of TAF(II)31 fails to stabilize p53. Our results suggest that direct interaction of TAF(II)31 and p53 not only mediates p53 transcriptional activation but also protects p53 from mdm2-mediated degradation, thereby resulting in activation of p53 functions.
引用
收藏
页码:13852 / 13857
页数:6
相关论文
共 37 条
  • [1] Stabilization of wild-type p53 by hypoxia-inducible factor 1α
    An, WG
    Kanekal, M
    Simon, MC
    Maltepe, E
    Blagosklonny, MV
    Neckers, LM
    [J]. NATURE, 1998, 392 (6674) : 405 - 408
  • [2] Regulation of p53 stability
    Ashcroft, M
    Vousden, KH
    [J]. ONCOGENE, 1999, 18 (53) : 7637 - 7643
  • [3] Activation of RNA polymerase II transcription
    Berk, AJ
    [J]. CURRENT OPINION IN CELL BIOLOGY, 1999, 11 (03) : 330 - 335
  • [4] ASSEMBLY OF RECOMBINANT TFIID REVEALS DIFFERENTIAL COACTIVATOR REQUIREMENTS FOR DISTINCT TRANSCRIPTIONAL ACTIVATORS
    CHEN, JL
    ATTARDI, LD
    VERRIJZER, CP
    YOKOMORI, K
    TJIAN, R
    [J]. CELL, 1994, 79 (01) : 93 - 105
  • [5] CORDONCARDO C, 1994, CANCER RES, V54, P794
  • [6] DEOCALUNA R, 1995, NATURE, V0378
  • [7] JNK targets p53 ubiquitination and degradation in nonstressed cells
    Fuchs, SY
    Adler, V
    Buschmann, T
    Yin, ZM
    Wu, XW
    Jones, SN
    Ronai, Z
    [J]. GENES & DEVELOPMENT, 1998, 12 (17) : 2658 - 2663
  • [8] Mdm2 association with p53 targets its ubiquitination
    Fuchs, SY
    Adler, V
    Buschmann, T
    Wu, XW
    Ronai, Z
    [J]. ONCOGENE, 1998, 17 (19) : 2543 - 2547
  • [9] MEKK1/JNK signaling stabilizes and activates p53
    Fuchs, SY
    Adler, V
    Pincus, MR
    Ronai, Z
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (18) : 10541 - 10546
  • [10] A subset of TAFIIs are integral components of the SAGA complex required for nucleosome acetylation and transcriptional stimulation
    Grant, PA
    Schieltz, D
    Pray-Grant, MG
    Steger, DJ
    Reese, JC
    Yates, JR
    Workman, JL
    [J]. CELL, 1998, 94 (01) : 45 - 53